Influenza Diagnostics Market to Reach USD 1.3 Billion by 2027 at a CAGR of 7.4% | Valuates Reports

influenza diagnostic tests with specificity and high sensitivity are major developments in influenza diagnostics over recent years. Reverse transcription-polymerase chain reaction (RT-PCR) and Nucleic acid labeling detection tests have greatly improved the ability to detect respiratory viruses. Additionally, molecular tests for influenza are mainly focused on the detection of specific known pathogens by NATs. NATs have several advantages over other existing diagnostic tools. They potentially can detect low levels of all-known influenza pathogens in clinical specimens, do not depend on the viability of the target microbe, and can provide results within a clinically relevant time frame.

The Influenza Diagnostics Market size is projected to reach USD 1.3 billion in 2027 from an estimated USD 0.86 billion in 2021, growing at a CAGR of 7.4% globally.

Market analysis, sizing, and forecast of the influenza diagnostics market are covered in the report. The country-level assessment of the market and associated forecasts are explained in the influenza diagnostics market report. The expansion of the influenza diagnostic controlling market dynamics intelligence that includes, market drivers, opportunities, supply chain, restraints, trends, value chain analysis, and Porter’s five forces are studied by MRFR analysts. Patent analysis outlook, Technology trends, and regulatory landscape of the market is detailed in the report to help investors acquire an in-depth understanding of the market and associated activities.

The Major Players In The Influenza Diagnostics Market Include:

Danaher Corporation (US), Siemens Healthineers (Germany), Thermo Fisher Scientific Inc. (US), F. Hoffmann-LA Roche AG (Switzerland), Abbott Laboratories Inc. (Us), Hologic Inc. (US), bioMérieux SA (France), Quidel Corporation (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), GenMark Diagnostics Inc. (US), Luminex Corporation (US), Tecan Trading AG (Switzerland), DiaSorin SA (Italy), altona Diagnostics GmbH (Germany), SEKISUI Diagnostics (US), SA Scientific Ltd. (US), Coris BioConcept SPRL (Belgium), ELITech Group (France), Mast Group Ltd. (UK), Genome Diagnostics Pvt. Ltd. (India), Germaine Laboratories Inc. (US), Response Biomedical Corp. (Canada), Tauns LaboratoriesInc. (Japan), 3B BlackBio Biotech India Ltd. (India)

Market has segmented the global Influenza Diagnostics market on the basis of type, application, and region:

The Influenza Diagnostics market is segmented by type and application. Growth between segments over the period 2022-2028 provides accurate calculations and forecasts of revenue by type and application in terms of volume and value. This analysis can help you expand your business by targeting eligible niches.

By Type:

 Traditional, Rapid Influenza Detection Tests, Viral Culture, Immunoassay Kits, Immunofluorescence Assays, And Serological Testing, Molecular, Rapid Molecular Assays, Reverse Transcription-Polymerase Chain , Reaction {RT-PCR}, And Nucleic Acid Amplification

 By Application:

 Clinical Laboratories, Hospitals, Research And Academic Institutes, And Diagnostic Laboratories

 By Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)
• Middle East & Africa (GCC Countries, South Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of South America)

Covid-19 Impact and Recovery Analysis on Industry:

The COVID-19 pandemic has had devastating effects on several industry verticals globally. To constrain the number of cases and slow the coronavirus spread, various public health guidelines were implemented in different countries across the globe. COVID-19 protocols ranging from declaring national emergency states, enforcing stay-at-home orders, closing nonessential business operations and schools, banning public gatherings, imposing curfews, distributing digital passes, and allowing police to restrict citizen movements within a country, as well as closing international borders. With the growing vaccination rate, governments are uplifting the protocols to give a boost to the stagnant economy. Like other industries, Influenza Diagnostics Market have experienced slowdown the growth, however market is expected bounce back as restrictions are being lifted up by governments across the globe. 

Key Points Covered in Influenza Diagnostics Industry Survey:

• Market Estimates and Forecasts (2022-2028)
• Key Drivers and Restraints Shaping Market Growth
• Segment-wise, Country-wise and Region-wise Analysis
• Competition Mapping and Benchmarking
• Market Share Analysis
• COVID-19 Impact on Demand for Influenza Diagnostics and How to Navigate
• Recommendation on Key Winning Strategies